ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Social Stream
ProQR Therapeutics NV (PRQR) Price Targets From Analysts
Use the tables below to see what analysts covering ProQR Therapeutics NV think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 16 months, PRQR's average price target has gone down $13.83.
Over the past 46 weeks, PRQR's average upside potential has been 311.62%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PRQR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 31 days, PRQR's average broker recommendation rating worsened by 0.6.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ProQR Therapeutics NV's upside potential (average analyst target price relative to current price) is greater than 586.13% of all US stocks.
- In terms of how ProQR Therapeutics NV fares relative to all US stocks, note that its variance in analysts' estimates is lower than -433.13% of that group.
- In terms of how ProQR Therapeutics NV fares relative to Healthcare stocks, note that its average analyst price target is greater than 130.41% of that group.
- ProQR Therapeutics NV's number of analysts covering the stock is higher than 419.7% of stocks in the small market cap category.
What is the outlook for PRQR? Use POWR Ratings for clearer insight into price direction.